Orexo and Lyfebulb Announce the Finalists and Jury for the 2020 Innovation Challenge in Substance Use Disorders
The Challenge recognizes Patient Entrepreneurs with solutions that aid successful, long-term recovery from alcohol and opioid use disordersUPPSALA, SWEDEN, AND NEW YORK, NY, USA, September 1[st], 2020: Orexo, a Swedish pharmaceutical company focused on improved pharmaceuticals and digital therapies, and Lyfebulb, a patient empowerment platform, announced the 10 Patient Entrepreneurs selected as finalists for the Lyfebulb and Orexo Innovation Challenge in substance use disorders. Motivated by personal connections to addiction and co-morbidities, the following finalists represent companies